首页> 外文期刊>Journal of Chemistry >Simultaneous Estimation and Validation for Determination of Lamivudine and Zidovudine in Human Plasma By LCMS/MS Method
【24h】

Simultaneous Estimation and Validation for Determination of Lamivudine and Zidovudine in Human Plasma By LCMS/MS Method

机译:LCMS / MS法测定人血浆中拉米夫定和Zidovine的同时估算和验证

获取原文
           

摘要

A high performance liquid chromatographic method with mass detection was developed for determination of Lamivudine and Zidovudine in human plasma. Lamivudine and Zidovudine were extracted from an aliquot of human plasma using Solid Phase Extraction technique, and then injected into a liquid chromatograph equipped with a tandem mass spectrometry detector; quantitation was done by peak area ratio method. A weighted (1/Conc2) linear regression was performed to determine the concentration of analyte. This method demonstrates acceptable performance and is suitable for the determination of Lamivudine and Zidovudine in human plasma over the range of 25.291 to 4046.621 ng/mL and 23.357 to 4057.l4lng/mL respectively using Solid Phase Extraction Procedure. As all the values obtained were within the limits as specified, the method has been successfully used to analyse the human plasma containing Lamivudine and Zidovudine with good recoveries and proved to be robust.
机译:开发了一种具有质谱的高性能液相色谱法,用于测定人血浆中拉米夫定和齐凡押。使用固相萃取技术从等分试样的人血浆中提取拉米夫定和齐凡,然后注入配备有串联质谱探测器的液相色谱仪;通过峰面积比法进行定量。进行加权(1 / COCH2)线性回归以确定分析物的浓度。该方法证明了可接受的性能,并且适用于使用固相萃取方法的25.291至4046.621ng / ml和23.357至4057.14Lng / mL的拉米夫定和齐凡替司法。随着所获得的所有值在规定的范围内,该方法已成功地用于分析含有较好的回收率的拉米夫定和Zidovine的人血浆,并被证明是鲁棒的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号